You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 54 No. 4, October 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Control of Experimental Herpes Simplex Virus Keratitis

Hormonal, Vaccine, and Antibiotic Therapy

JOSEPH W. HALLETT, M.D.; KHALIDA NAIB, M.D.; IRVING H. LEOPOLD, M.D.

AMA Arch Ophthalmol. 1955;54(4):573-579.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The treatment of experimental herpes simplex virus keratitis with cortisone or corticotropin locally or systemically has been uniformly unfavorable or ineffective in the experience of several groups of investigators.* This is not peculiar to the herpes simplex virus, because the same undesirable results have occurred in the treatment of experimental poliomyelitis5 and in Coxsackie,6 influenza,{dagger} and mumps8 virus infections. Presumably, these infections have a minimal hypersensitivity factor, since it is in the control of the latter that cortisone excels. Several other effects, however, on tissue resistance and immunity have been ascribed to cortisone. As Leopold9 has pointed out, these actions are generally inhibitory in that there is a decrease not only in allergic responses but also in inflammatory responses to topical injury, in granuloma formation, and in resistance to certain infections.

According to Selye,10 in distinct contrast to cortisone, the somatotropic hormone (STH), the so-called . . . [Full Text PDF of this Article]


Author Affiliations

Philadelphia With the Technical Assistance of S. Inwald and M. McCleary

From the Research Department, Wills Eye Hospital.


Footnotes

Submitted for publication July 11, 1955.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.